FibroGen Inc. | Cash Flow
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
14,943.00
59,504.00
85,779.00
61,680.00
126,203.00
86,420
Depreciation, Depletion & Amortization
5,084.00
4,470.00
5,679.00
6,040.00
6,099.00
6,562
Other Funds
175.00
175,933.00
-
2,740.00
462,909.00
52,112
Funds from Operations
5,876.00
35,688.00
49,527.00
21,027.00
80,859.00
27,746
Changes in Working Capital
31,794.00
58,102.00
30,956.00
28,135.00
14,346.00
48,430
Net Operating Cash Flow
25,918.00
22,414.00
18,571.00
7,108.00
66,513.00
76,176
Capital Expenditures
6,806.00
8,118.00
1,977.00
1,252.00
8,500.00
Sale of Fixed Assets & Businesses
2.00
10.00
2.00
-
5.00
Purchase/Sale of Investments
17,582.00
99,181.00
3,893.00
7,874.00
78,361.00
Net Investing Cash Flow
10,778.00
107,289.00
5,868.00
6,622.00
69,866.00
Issuance/Reduction of Debt, Net
421.00
3,538.00
403.00
403.00
1,347.00
Net Financing Cash Flow
680.00
174,092.00
12,346.00
6,738.00
496,472.00
Net Change in Cash
37,460.00
89,123.00
12,131.00
20,458.00
499,876.00
Free Cash Flow
19,112.00
14,296.00
20,548.00
5,856.00
75,013.00
Change in Capital Stock
84.00
1,697.00
12,749.00
9,881.00
34,910.00
Exchange Rate Effect
84.00
94.00
38.00
10.00
51.00
About FibroGen
View Profile
